Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé

1 result

  • Language : Français
  • Active substance : chymotrypsine
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
  • Diseases and conditions (1)
  • Plus ...
    • Respiratory tract diseases (1)
    • Plus ...
      • Respiratory tract diseases - miscellaneous (1)
    • Otorhinolaryngologic diseases (1)
    • Plus ...
      • Nose and sinus diseases (1)
    • Infectious diseases (1)
    • Plus ...
      • Parasitic diseases and mycoses (1)
    • Immune system diseases (1)
    • Plus ...
      • Immunologic deficiency syndromes (1)
      • Allergy (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Fabricant
  • industriels (1)
Langue
  • Français (1)
Substance active
  • catalase (1)
  • chymotrypsine (1)
  • ciclosporine (1)
  • fer (1)
  • flucytosine (1)
  • galactose (1)
  • itraconazole (1)
  • levure (1)
  • posaconazole (1)
  • prednisone (1)
  • tazobactam (1)
  • voriconazole (1)
More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 1 result

  • Modification of the Nomenclature of Procedures in Laboratory Medicine for the diagnostic laboratory procedures for Aspergillus diseases - INAHTA Brief

    Health technology assessment - Posted on 9/6/2017 - Mis à jour le 9/6/2017
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
rune4VQhy0LTg321